Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Hospitals & Health Networks|November 5, 2003
13th Annual Contract Management SurveyJennifer Towne, Suzanna HoppszallernHospitals & Health Networks|March 18, 2005
Information technology ROI. A CEO's Guide to measuring and evaluating IT's financial effectivenessLee Ann Runy, Jennifer TowneHospitals & Health Networks|May 9, 2003
Consumer confusionLee Ann Runy, Jennifer Towne, Suzanna Hoppszallern, et al.Plos One|August 12, 2014
Blockade of IL-36 receptor signaling does not prevent from TNF-induced arthritisAnja Derer, Bettina Groetsch, Ulrike Harre, et al.Plos One|February 21, 2020
The PAR2 signal peptide prevents premature receptor cleavage and activationBelinda Liu, Grace Lee, Jiejun Wu, et al.Nature Immunology|August 20, 2003
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signalingDavid Wald, Jinzhong Qin, Zhendong Zhao, et al.Cytokine|June 4, 2016
Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokinesDamien Dietrich, Praxedis Martin, Vincent Flacher, et al.Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Preclinical Human IBD MechanismsTheresa T Pizarro, Thaddeus S Stappenbeck, Florian Rieder, et al.Scientific Reports|July 30, 2024
JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humansAnne M Fourie, Xiaoli Cheng, Leon Chang, et al.Pageof 2